{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:32:55Z","timestamp":1761975175420,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1378\/chest.10-0128","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T01:44:31Z","timestamp":1294105471000},"page":"190-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Beneficial Effects of Treatment With Anti-IgE Antibodies (Omalizumab) in a Patient With Severe Asthma and Negative Skin-Prick Test Results"],"prefix":"10.1016","volume":"139","author":[{"given":"Maarten","family":"van den Berge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Pauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.R.","family":"de Monchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees A.","family":"van Minnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirkje S.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huib A.M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1378\/chest.10-0128_bib1","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1164\/ajrccm.155.6.9196082","article-title":"The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects","volume":"155","author":"Fahy","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1378\/chest.10-0128_bib2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.155.6.9196083","article-title":"Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response","volume":"155","author":"Boulet","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.10-0128_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2222.2004.1916.x","article-title":"Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma","volume":"34","author":"Holgate","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1378\/chest.10-0128_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1378\/chest.10-0128_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1081-1206(10)62691-9","article-title":"Efficacy of a single diagnostic test for sensitization to common inhalant allergens","volume":"86","author":"Williams","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1378\/chest.10-0128_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1183\/09031936.02.00278102","article-title":"Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma","volume":"20","author":"Buhl","year":"2002","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1378\/chest.10-0128_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"issue":"2","key":"10.1378\/chest.10-0128_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1183\/09031936.01.00092101","article-title":"The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics","volume":"18","author":"Sol\u00e8r","year":"2001","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1378\/chest.10-0128_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/rccm.200312-1651OC","article-title":"Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma","volume":"170","author":"Djukanovi\u0107","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"author":"Global Initiative of Asthma (GINA) guidelines","key":"10.1378\/chest.10-0128_bib10"},{"issue":"7","key":"10.1378\/chest.10-0128_bib11","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.4049\/jimmunol.158.7.3539","article-title":"Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics","volume":"158","author":"Ying","year":"1997","journal-title":"J Immunol"},{"issue":"5","key":"10.1378\/chest.10-0128_bib12","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/ajrccm.154.5.8912771","article-title":"IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against \u201cintrinsic\u201d asthma being a distinct immunopathologic entity","volume":"154","author":"Humbert","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1378\/chest.10-0128_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0091-6749(97)70028-9","article-title":"Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma","volume":"99","author":"Humbert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1378\/chest.10-0128_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1034\/j.1399-3003.2000.16d07.x","article-title":"Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals","volume":"16","author":"Beeh","year":"2000","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1378\/chest.10-0128_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0091-6749(82)90042-2","article-title":"The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders","volume":"70","author":"Burrows","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.10-0128_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000100897","article-title":"Role of staphylococcal superantigens in airway disease","volume":"93","author":"Bachert","year":"2007","journal-title":"Chem Immunol Allergy"},{"issue":"3","key":"10.1378\/chest.10-0128_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1067\/mai.2001.113047","article-title":"Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection","volume":"107","author":"ten Brinke","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1378\/chest.10-0128_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1074-7613(01)00159-5","article-title":"Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival","volume":"14","author":"Kalesnikoff","year":"2001","journal-title":"Immunity"},{"issue":"4","key":"10.1378\/chest.10-0128_bib19","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.4049\/jimmunol.178.4.2535","article-title":"IgE modulates neutrophil survival in asthma: role of mitochondrial pathway","volume":"178","author":"Saffar","year":"2007","journal-title":"J Immunol"},{"issue":"2\u20134","key":"10.1378\/chest.10-0128_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000024158","article-title":"Regulation of FcepsilonARI synthesis in human eosinophils","volume":"118","author":"Bjerke","year":"1999","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369211600329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369211600329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:22:02Z","timestamp":1757917322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369211600329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0012369211600329"],"URL":"https:\/\/doi.org\/10.1378\/chest.10-0128","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial Effects of Treatment With Anti-IgE Antibodies (Omalizumab) in a Patient With Severe Asthma and Negative Skin-Prick Test Results","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.10-0128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1378\/chest.10-2216","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}